WallStreetZenWallStreetZen

NASDAQ: ENGN
Engene Therapeutics Inc Stock Ownership - Who owns Engene Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Engene Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ENGN insiders and whales buy or sell their stock.

ENGN Shareholders

What type of owners hold Engene Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fcpm III Services Bv14.38%9,632,561$16.09MInstitution
Forbion Growth Opportunities Fund I Cooperatief Ua10.15%6,798,362$11.35MInsider
Perceptive Advisors LLC8.70%5,827,506$9.73MInstitution
Siren LLC7.84%5,253,159$8.77MInstitution
Venrock Adviser LLC7.12%4,771,414$7.97MInstitution
Blue Owl Capital Holdings LP6.59%4,416,353$7.38MInstitution
Deep Track Capital LP6.53%4,377,572$7.31MInstitution
Lumira Capital Investment Management Inc5.75%3,849,299$6.43MInsider
De Solidarite Des Travailleurs Du Quebec Fonds4.53%3,036,153$5.07MInsider
Forbion Capital Fund III Cooperatief Ua4.32%2,894,735$4.83MInsider

1 of 3

ENGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENGN74.60%25.40%
PLYX4.79%56.56%Net BuyingNet Buying
OTLK4.87%95.13%Net BuyingNet Buying
BDTX65.60%34.40%Net BuyingNet Buying
PYXS43.52%37.01%
View Top Biotech Stocks

Engene Therapeutics Stock Ownership FAQ

Who owns Engene Therapeutics?

Engene Therapeutics (NASDAQ: ENGN) is owned by 83.30% institutional shareholders, 28.36% Engene Therapeutics insiders, and 0.00% retail investors. Forbion Growth Opportunities Fund I Cooperatief Ua is the largest individual Engene Therapeutics shareholder, owning 6.80M shares representing 10.15% of the company. Forbion Growth Opportunities Fund I Cooperatief Ua's Engene Therapeutics shares are currently valued at $10.88M.

If you're new to stock investing, here's how to buy Engene Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.